Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fruquintinib”

177 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 177 results

Not applicableNot Yet RecruitingNCT06464601
What this trial is testing

A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Wuhan University 70
Not applicableUnknownNCT05928312
What this trial is testing

Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Zhejiang Cancer Hospital 72
Not applicableWithdrawnNCT06221423
What this trial is testing

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Fudan University
Testing effectiveness (Phase 2)UnknownNCT05575635
What this trial is testing

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

Who this might be right for
Rectal Cancer
Henan Provincial People's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07502014
What this trial is testing

A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (CRC)mCRC
Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)UnknownNCT05511051
What this trial is testing

A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Not applicableLooking for participantsNCT06102785
What this trial is testing

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06356584
What this trial is testing

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Who this might be right for
Colorectal CancerImmunotherapyRadiotherapy+2 more
Shandong Cancer Hospital and Institute 62
Testing effectiveness (Phase 2)Looking for participantsNCT06856837
What this trial is testing

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 140
Testing effectiveness (Phase 2)UnknownNCT05257122
What this trial is testing

A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Carcinoma
Fudan University 32
Early research (Phase 1)Study completedNCT05216354
What this trial is testing

Fruquintinib Renal Impairment Study

Who this might be right for
Renal Impairment
Hutchmed 24
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT05914610
What this trial is testing

Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Fujian Medical University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746545
What this trial is testing

A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Fujian Cancer Hospital 30
Not applicableNot Yet RecruitingNCT06553781
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma

Who this might be right for
Malignant Melanoma
Fudan University 28
Large-scale testing (Phase 3)Study completedNCT02314819
What this trial is testing

A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)

Who this might be right for
Colorectal Cancer
Hutchison Medipharma Limited 416
Testing effectiveness (Phase 2)WithdrawnNCT05690035
What this trial is testing

Tislelizumab Combined With Fruquintinib for Metastatic pMMR/MSS Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancermCRC
Sun Yat-sen University
Testing effectiveness (Phase 2)Active Not RecruitingNCT05831891
What this trial is testing

Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Non-clear Cell Renal Cell Carcinoma
RenJi Hospital 40
Testing effectiveness (Phase 2)UnknownNCT05625737
What this trial is testing

Fruquintinib Combined with Sintilimab As Second-line Therapy for Gastric or Gastro-esophageal Junction Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 29
Testing effectiveness (Phase 2)UnknownNCT05555901
What this trial is testing

The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 116
Next Page